Prnewswire·2025-10-22 20:10Core Insights - Globe Life Inc. reported a net income of $4.73 per diluted common share for Q3 2025, up from $3.44 in the same quarter last year, indicating a 38% increase [1][7][35] - Net operating income also rose to $4.81 per diluted common share from $3.49, reflecting a 38% year-over-year growth [1][7][35] - The company experienced a remeasurement gain of $134.3 million in Q3 2025, compared to a $46.3 million gain in the prior year, driven by updated assumptions [2][7] Financial Performance - Total revenue for Q3 2025 was $1.51 billion, compared to $1.46 billion in Q3 2024, marking a 4% increase [35] - Life insurance premiums increased by 3% to $844.5 million, while health insurance premiums rose by 9% to $386.5 million [11][35] - The insurance underwriting income for the quarter was $503.1 million, a 30% increase from $387.4 million in Q3 2024 [13][35] Investment Performance - Excess investment income for Q3 2025 was $36.9 million, down 7% from $39.5 million in Q3 2024 [23][35] - The investment portfolio's total book value as of September 30, 2025, was $20.33 billion, with fixed maturities accounting for 88% of the total [25][35] - The fixed maturity portfolio earned an annual taxable equivalent effective yield of 5.26% during Q3 2025, slightly up from 5.25% in the previous year [27][35] Insurance Operations - Life insurance accounted for 82% of the company's insurance underwriting margin, while health insurance made up 18% [10][35] - Net sales of life insurance increased by 2%, and net health sales surged by 21% compared to the previous year [10][17] - The average producing agent count increased by 9% year-over-year, indicating growth in distribution capabilities [7][20] Shareholder Actions - The company repurchased 840,242 shares of its common stock at a total cost of $113 million during the quarter [29][35] - Globe Life projects net operating income between $14.40 to $14.60 per diluted common share for the year ending December 31, 2025 [30][35]